Ventricular tachycardia syndromes.
Better understanding of the underlying mechanism and substrate of different VTs has made it possible to tailor treatment strategies properly. The advent of sophisticated device-based therapy and of more precise and effective catheter ablation approaches will expand clinicians' ability to gain control of this multifaceted arrhythmia syndrome.
Department of Cardiology, Section of Pacing and Electrophysiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
W I
WI
Saliba
A
A
Natale
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications; D017115:Catheter Ablation; D003327:Coronary Disease / Q000150:complications; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D013577:Syndrome; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D014481:United States / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents